Log in

Relevant bibliographies by topics / Peripheral vascular diseases / Journal articles

To see the other types of publications on this topic, follow the link: Peripheral vascular diseases.

Journal articles on the topic 'Peripheral vascular diseases'

Author: Grafiati

Published: 4 June 2021

Last updated: 28 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Peripheral vascular diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

MALIK, GULZAR AHMAD, KASHIF KURSHID QURESHI, IMTIAZ AHMAD, and Muhammad Afzal. "PERIPHERAL VASCULAR DISEASES." Professional Medical Journal 14, no. 01 (March 10, 2007): 134–44. http://dx.doi.org/10.29309/tpmj/2007.14.01.3640.

Full text

Abstract:

Objectives: To observe the prevalence & presentation and to review the noninvasive approaches for the evaluation and treatment of patients presenting with peripheral vascular diseases at Bahawal Victoria Hospital Bahawalpur. Design: Prospective randomized study. Place and Duration: This study was conducted from July 2003 to June 2005 at the department of Surgery Bahawal Victoria Hospital Bahawalpur. Patients & Methods: Twenty patients, 2 females and 18 males admitted with peripheral vascular diseases (PVD) fulfilling the inclusion criteria were evaluated and treated medically and surgically. A standard noninvasive approach for the evaluation of these patients was adopted by history & thorough clinical examination, Doppler USG of the vessels, Ankle Brachial Indices (ABI), Duplex Scanning and MRI in a few cases. Results: The relative frequency of PVD at BVH Bahawalpur was 1.2%. The majority of patients (60%) were in the 4th decade of life and male (90%). The smoking was exclusively the major predisposing risk factor (90%). The common (90%) presentation of patients was intermittent claudication with 60% gangrenous disease with an average duration of 4years, The lower limbs were involved in 90% cases with 70% bilateral disease. Majority (90%) of the patients was diagnosed clinically and the objective severity of the disease was assessed with Doppler sonography in all the patients. The ABI was <0.5 in 85% cases. The duplex scanning was needed only in 10% patients. The treatment procedures carried out were primary amputation in 45% followed by conservative on medicines 20%, atherectomy in 15%, lumbar sympathectomy in 10% and resection or repair of pseudoaneurysms in 10% of cases. The ultimate rate of amputation at various levels was seen to be 75%. Conclusion: The prevalence of PVD is rapidly increasing in our society which is causing a horrible threat in the form of physical disabilities at a younger age group of poor class mostly. Smoking remains exclusively the only major risk factor. Much time and money can be saved by evaluating and treating these patients by noninvasive approaches but prevention is the besttherapeutic strategy achieving by abstinence from the smoking.

APA, Harvard, Vancouver, ISO, and other styles

2

Stewart, J. H. "Peripheral Vascular Diseases." Cardiovascular Research 27, no. 5 (May 1, 1993): 891–92. http://dx.doi.org/10.1093/cvr/27.5.891a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Taylor, Lloyd M. "Peripheral vascular diseases." Journal of Vascular Surgery 16, no. 3 (September 1992): 507. http://dx.doi.org/10.1016/0741-5214(92)70058-s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Taylor, Lloyd M. "Peripheral vascular diseases." Journal of Vascular Surgery 16, no. 3 (September 1992): 505–6. http://dx.doi.org/10.1016/0741-5214(92)90406-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Zarins, Christopher K. "Peripheral Vascular Diseases." JAMA: The Journal of the American Medical Association 268, no. 4 (July 22, 1992): 543. http://dx.doi.org/10.1001/jama.1992.03490040127038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

McPherson, S. "Peripheral vascular diseases." International Journal of Cardiology 38, no. 1 (January 1993): 106. http://dx.doi.org/10.1016/0167-5273(93)90219-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Robbins, Jeffrey M., and Corliss L. Austin. "COMMON PERIPHERAL VASCULAR DISEASES." Clinics in Podiatric Medicine and Surgery 10, no. 2 (April 1993): 205–19. http://dx.doi.org/10.1016/s0891-8422(23)00599-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Skversky, Norman J., Allen B. Herring, and Raymond C. Baron. "THERMOGRAPHY IN PERIPHERAL VASCULAR DISEASES." Annals of the New York Academy of Sciences 121, no. 1 (December 16, 2006): 118–34. http://dx.doi.org/10.1111/j.1749-6632.1964.tb13691.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Gelabert, Hugh. "Color atlas of peripheral vascular diseases." Journal of Vascular Surgery 26, no. 1 (July 1997): 174. http://dx.doi.org/10.1016/s0741-5214(97)70170-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Wang, Hsin-Kai, Yi-Hong Chou, Hong-Jen Chiou, See-Ying Chiou, and Cheng-Yen Chang. "B-flow Ultrasonography of Peripheral Vascular Diseases." Journal of Medical Ultrasound 13, no. 4 (2005): 186–95. http://dx.doi.org/10.1016/s0929-6441(09)60108-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Allison, D. J., and A. Kennedy. "ABC of vascular diseases. Peripheral arteriovenous malformations." BMJ 303, no. 6811 (November 9, 1991): 1191–94. http://dx.doi.org/10.1136/bmj.303.6811.1191.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Forbes, C., and G. C. Leng. "Peripheral vascular diseases and the Cochrane Collaboration." Gefässchirurgie 4, no. 2 (May 1999): 81–84. http://dx.doi.org/10.1007/pl00010547.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Bradbury, A. W., and C. V. Ruckley. "Cochrane Review Group on Peripheral Vascular Diseases." British Journal of Surgery 82, no. 12 (December 1995): 1654. http://dx.doi.org/10.1002/bjs.1800821223.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Gregory, Jeff K., and C. Stephen Foster. "Peripheral Ulcerative Keratitis in the Collagen Vascular Diseases." International Ophthalmology Clinics 36, no. 1 (1996): 21–30. http://dx.doi.org/10.1097/00004397-199603610-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Yu, Hsin-Su, Chih-Hung Lee, and Gwo-Shing Chen. "Peripheral Vascular Diseases Resulting from Chronic Arsenical Poisoning." Journal of Dermatology 29, no. 3 (March 2002): 123–30. http://dx.doi.org/10.1111/j.1346-8138.2002.tb00234.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Royle, E. M., J. A. Michaels, and G. C. Leng. "Cochrane collaborative review group on peripheral vascular diseases." European Journal of Vascular and Endovascular Surgery 16, no. 1 (July 1998): 1–3. http://dx.doi.org/10.1016/s1078-5884(98)80082-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Dyakova, S., S. V. Dyakova, and A. V. Ivanov. "O.479 Diagnostic of peripheral vascular reticulum diseases." Journal of Cranio-Maxillofacial Surgery 36 (September 2008): S120. http://dx.doi.org/10.1016/s1010-5182(08)71603-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Dabas, Ajay Kumar, Rishi Dhillan, and Raghvinder Pal Singh Gambhir. "Journey of hybrid procedures in peripheral vascular diseases." Journal of Vascular Surgery 66, no. 1 (July 2017): 323–25. http://dx.doi.org/10.1016/j.jvs.2017.01.039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Ulutin, O. N., N. İlhan-Berkel, H. Tunali, M. Özer, Ş. Balkuv-Ulutin, Ç. Önsel, and I. Urgancioǧ;lu. "Effects of Defibrotide on Peripheral Obliterative Vascular Diseases." Pathophysiology of Haemostasis and Thrombosis 16, no. 1 (1986): 59–62. http://dx.doi.org/10.1159/000215344.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Namratha MV, Prashanth Jain, and Geetha B Markande. "Understanding the etiopathogenesis of Uttana Vatarakta (peripheral vascular disease) - An Observational Study." Journal of Ayurveda and Integrated Medical Sciences 7, no. 6 (August 13, 2022): 77–86. http://dx.doi.org/10.21760/jaims.7.6.11.

Full text

Abstract:

Advanced life style and changing food habits affects the activities of individual which leads to many diseases and Peripheral Vascular Diseases are one among them. They are characterized by reduction of blood flow and oxygen supply through peripheral vascular vessels. This can happen in arteries or veins. The incidence of Varicose vein is more common with age and high prevalence is after 30 years of life. PAD occurs in patients over 40 years old; the highest incidence occurs in the sixth and seventh decades of life and it affects 10-15% of the general population. The symptoms of Uttana Vatarakta owing to the Margavarana pathology simulate with the symptoms of Peripheral vascular diseases and some of the etiological factors of Uttana Vatarakta in the writing are specific in inclining Peripheral Vascular Diseases. Ayurveda emphasise the importance of study on etiopathogenesis of disease before the planning of treatment protocol. In this study an effort is done to identify the Nidanas and pattern of Samprapti in relation with Peripheral vascular diseases for the better understanding of different clinical presentations of Uttana Vatarakta.

APA, Harvard, Vancouver, ISO, and other styles

21

Agrawal, Swati, Sunil K. Nooti, Harbinder Singh, and Vikrant Rai. "Nanomaterial-Mediated Theranostics for Vascular Diseases." Journal of Nanotheranostics 2, no. 1 (December 22, 2020): 1–15. http://dx.doi.org/10.3390/jnt2010001.

Full text

Abstract:

Nanotechnology could offer a new complementary strategy for the treatment of vascular diseases including coronary, carotid, or peripheral arterial disease due to narrowing or blockage of the artery caused by atherosclerosis. These arterial diseases manifest correspondingly as angina and myocardial infarction, stroke, and intermittent claudication of leg muscles during exercise. The pathogenesis of atherosclerosis involves biological events at the cellular and molecular level, thus targeting these using nanomaterials precisely and effectively could result in a better outcome. Nanotechnology can mitigate the pathological events by enhancing the therapeutic efficacy of the therapeutic agent by delivering it at the point of a lesion in a controlled and efficacious manner. Further, combining therapeutics with imaging will enhance the theranostic ability in atherosclerosis. Additionally, nanoparticles can provide a range of delivery systems for genes, proteins, cells, and drugs, which individually or in combination can address various problems within the arteries. Imaging studies combined with nanoparticles helps in evaluating the disease progression as well as the response to the treatment because imaging and diagnostic agents can be delivered precisely to the targeted destinations via nanocarriers. This review focuses on the use of nanotechnology in theranostics of coronary artery and peripheral arterial disease.

APA, Harvard, Vancouver, ISO, and other styles

22

Breddin, Hans Klaus. "Antiplatelet Agents in Cardiovascular and Cerebrovascular Diseases." Clinical and Applied Thrombosis/Hemostasis 4, no. 2 (April 1998): 87–95. http://dx.doi.org/10.1177/107602969800400203.

Full text

Abstract:

Aspirin has become a widely accepted platelet function inhibitor and is used to prevent arterial occlusions in coronary cerebral and peripheral vascular disease. The results of clinical studies with aspirin in the area of peripheral arterial occlusive disease are critically reviewed. Two thienopyridine compounds, ticlopidine and clopidogrel, have been effectively used in the prevention of myocardial infarction and stroke in several clinical trials, especially in the recently published CAPRIE-trial. Potent new platelet function inhibitors recently were developed. Intravenous treatment with abciximab, a new platelet membrane glycoprotein IIb/IIIa-inhibitor, effectively prevented coronary reocclusions in patients with high-risk coronary events. A series of promising new oral IIb/IIIa- inhibitors have been developed and may become effective drugs in the prevention of reocclusions in patients with periph eral vascular disease and in coronary or cerebral vascular dis ease. Key Words: Antiplatelet agents—Aspirin—Peripheral arterial disease—Ticlopidine—Clopidogrel—GPIIb/IIIa inhibitor.

APA, Harvard, Vancouver, ISO, and other styles

23

Ferrannini, M., G. Vischini, E. Staffolani, F. Scaccia, N. Miani, M. C. Parravano, M. M. Louis, G. Splendiani, and N. Di Daniele. "Rheopheresis in Vascular Diseases." International Journal of Artificial Organs 30, no. 10 (October 2007): 923–29. http://dx.doi.org/10.1177/039139880703001010.

Full text

Abstract:

Background Endothelial dysfunction is a common condition in many microvascular diseases, such as Age-related Macular Degeneration (AMD) and Peripheral Arterial Occlusive Disease (PAOD). Rheopheresis therapy improves ematic viscosity, shear stress and endothelial function while decreasing fibrinogen, LDL-cholesterol and alpha-2-macroglobulin levels. Objective To evaluate the therapeutic efficacy of rheopheresis in patients with microcirculatory diseases. Materials and Methods Eight patients (7 male and 1 female) were treated with rheopheresis: 3 males were affected by AMD, 4 male and 1 female by uremia and PAOD. We used Membrane Differential Filtration (MDF) with an ethinylvinylalcohol copolymer membrane as plasmafiltrator. Patients with AMD were treated once a week for ten weeks. Patients affected with PAOD were treated twice weekly for 3 weeks and then were placed on a once-a-week program. Results In all treated patients with AMD, visual acuity improved. In all patients affected with PAOD, we observed a complete resolution of pain; 3 out of 5 had a complete remission of ulcers. There was partial reduction of ulcers in the other patients and no adverse effects were observed. Conclusion: Rheopheresis is a safe, effective form of hemorheotherapy

APA, Harvard, Vancouver, ISO, and other styles

24

Opincariu, Diana, András Mester, Imre Benedek, and István Benedek. "Stem Cell Therapies in Peripheral Vascular Diseases — Current Status." Journal of Interdisciplinary Medicine 2, s4 (December 1, 2017): 12–19. http://dx.doi.org/10.1515/jim-2017-0093.

Full text

Abstract:

AbstractPeripheral artery diseases include all arterial diseases with the exception of coronary and aortic involvement, more specifically diseases of the extracranial carotids, upper limb arteries, mesenteric and renal vessels, and last but not least, lower limb arteries. Mononuclear stem cells, harvested from various sites (bone marrow, peripheral blood, mesenchymal cells, adipose-derived stem cells) have been studied as a treatment option for alleviating symptoms in peripheral artery disease, as potential stimulators for therapeutic angiogenesis, thus improving vascularization of the ischemic tissue. The aim of this manuscript was to review current medical literature on a novel treatment method — cell therapy, in patients with various peripheral vascular diseases, including carotid, renal, mesenteric artery disease, thromboangiitis obliterans, as well as upper and lower limb artery disease.

APA, Harvard, Vancouver, ISO, and other styles

25

Nakashima, Rieko, and Yoshinori Inoue. "3. Vascular Laboratory and Diagnosis of Peripheral Arterial Diseases." Nihon Naika Gakkai Zasshi 97, no. 2 (2008): 304–8. http://dx.doi.org/10.2169/naika.97.304.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Spasojevic, Natalija, and Predrag Brkic. "Effect of hyperbaric oxygen therapy on peripheral vascular diseases." Medicinski podmladak 68, no. 4 (2017): 27–31. http://dx.doi.org/10.5937/mp68-13736.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

SELVAAG, OTTO, and ROLF HOLMBOE. "Intraarterial Treatment of Obliterative Peripheral Vascular Diseases with Tetraethylammoniumbromide." Acta Medica Scandinavica 142, no. 2 (April 24, 2009): 132–42. http://dx.doi.org/10.1111/j.0954-6820.1952.tb13852.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Yücel, Cihan, Mete Gürsoy, Serkan Ketenciler, Burçin Çayhan Karademir, and Nihan Kayalar. "Our Hybrid Approach in the Treatment of Peripheral Vascular Diseases." European Archives of Medical Research 37, no. 3 (September 16, 2021): 158–61. http://dx.doi.org/10.4274/eamr.galenos.2020.69672.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Mikita, János, Péter Ilonczai, and Judit Tóth. "Local thrombolysis in the treatment of peripheral arterial vascular diseases." Orvosi Hetilap 148, no. 37 (September 1, 2007): 1737–44. http://dx.doi.org/10.1556/oh.2007.28196.

Full text

Abstract:

A verőereket szisztémásan érintő atheroscleroticus folyamat jellemzői az időben elhúzódó progresszivitás mellett a hirtelen kialakuló, trombózissal, embolizációval kapcsolatos érelzáródások is. A különböző lokalizációjú perifériás artériás érbetegség fulmináns formája igen súlyos klinikai tünetek kíséretében manifesztálódik. A gyors diagnosztikát követően az érsebész, a radiológus és az angiológus belgyógyász konzultációja utáni terápiában manapság egyre markánsabb hely illeti meg a lokális thrombolysist. A módszer lényege a thrombusba helyezett katéteren keresztül infúzióban elnyújtottan adott szöveti plazminogén aktivátor thrombolyticus hatásának kihasználása. A revascularisatiós eredmény angiográfiával ellenőrizhető. A szerzők bemutatják a lokális thrombolyticus kezelés indikációit és kontraindikációit perifériás artériás érbetegségben, majd két saját esetük rövid prezentálásával is alátámasztják a kérdés aktuális fontosságát. Diszkutálják a nemzetközi szakirodalom adatait, melyek általános megállapításaként az hangsúlyozandó, hogy a lokálisan alkalmazott thrombolysis egyenértékű az érsebészeti beavatkozással. Bizonyos helyzetekben, igen komplex okokkal kapcsolatban az elsőként választandó kezelési eljárásként ajánlható. A téma feldolgozásakor levonható legfontosabb tanulságok, a jövőbeli fejlődés várható útjainak bemutatásával zárul a referátum.

APA, Harvard, Vancouver, ISO, and other styles

30

Hines, E. A. "EFFECTS OF SMOKING IN DISEASES OF THE PERIPHERAL VASCULAR SYSTEM." Annals of the New York Academy of Sciences 90, no. 1 (December 15, 2006): 333–44. http://dx.doi.org/10.1111/j.1749-6632.1960.tb32648.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Aboyans, Victor, and Lucia Mazzolai. "The ESC Working Group on Aorta & Peripheral Vascular Diseases." European Heart Journal 41, no. 44 (November 21, 2020): 4221–23. http://dx.doi.org/10.1093/eurheartj/ehaa620.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Fowkes, F. G. R. "Cochrane Collaborative Review Group on Peripheral Vascular Diseases: Review Abstract." European Journal of Vascular and Endovascular Surgery 18, no. 4 (October 1999): 282–83. http://dx.doi.org/10.1053/ejvs.1999.0955.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Mukherjee, D., and J. S. Yadav. "Update on peripheral vascular diseases: from smoking cessation to stenting." Cleveland Clinic Journal of Medicine 68, no. 8 (August 1, 2001): 723–33. http://dx.doi.org/10.3949/ccjm.68.8.723.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Henry, Michel, Richard Béron, Claude Amicabile, Pascal Voiriot, and Alain Chastel. "Palmaz-schatz stents in the treatment of peripheral vascular diseases." Journal of the American College of Cardiology 17, no. 2 (February 1991): A302. http://dx.doi.org/10.1016/0735-1097(91)92175-l.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Peripheral Vascular Diseases Group. "Cochrane Collaborative Review Group on Peripheral Vascular Diseases: Review Abstracts." European Journal of Vascular and Endovascular Surgery 30, no. 5 (November 2005): 457–60. http://dx.doi.org/10.1016/j.ejvs.2005.06.024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Maxwell, H. "Cochrane Collaborative Review Group on Peripheral Vascular Diseases: Review Abstracts." European Journal of Vascular and Endovascular Surgery 32, no. 5 (November 2006): 475–77. http://dx.doi.org/10.1016/j.ejvs.2006.07.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Hess, David A., Subodh Verma, Deepak Bhatt, Ehab Bakbak, Daniella C. Terenzi, Pankaj Puar, and Francesco Cosentino. "Vascular repair and regeneration in cardiometabolic diseases." European Heart Journal 43, no. 6 (November 24, 2021): 450–59. http://dx.doi.org/10.1093/eurheartj/ehab758.

Full text

Abstract:

Abstract Chronic cardiometabolic assaults during type 2 diabetes (T2D) and obesity induce a progenitor cell imbalance in the circulation characterized by overproduction and release of pro-inflammatory monocytes and granulocytes from the bone marrow alongside aberrant differentiation and mobilization of pro-vascular progenitor cells that generate downstream progeny for the coordination of blood vessel repair. This imbalance can be detected in the peripheral blood of individuals with established T2D and severe obesity using multiparametric flow cytometry analyses to discern pro-inflammatory vs. pro-angiogenic progenitor cell subsets identified by high aldehyde dehydrogenase activity, a conserved progenitor cell protective function, combined with lineage-restricted cell surface marker analyses. Recent evidence suggests that progenitor cell imbalance can be reversed by treatment with pharmacological agents or surgical interventions that reduce hyperglycaemia or excess adiposity. In this state-of-the-art review, we present current strategies to assess the progression of pro-vascular regenerative cell depletion in peripheral blood samples of individuals with T2D and obesity and we summarize novel clinical data that intervention using sodium-glucose co-transporter 2 inhibition or gastric bypass surgery can efficiently restore cell-mediated vascular repair mechanisms associated with profound cardiovascular benefits in recent outcome trials. Collectively, this thesis generates a compelling argument for early intervention using current pharmacological agents to prevent or restore imbalanced circulating progenitor content and maintain vascular regenerative cell trafficking to sites of ischaemic damage. This conceptual advancement may lead to the design of novel therapeutic approaches to prevent or reverse the devastating cardiovascular comorbidities currently associated with T2D and obesity.

APA, Harvard, Vancouver, ISO, and other styles

38

Mourão, Daniel, Luís Paiva, and Catarina Lobão. "Lower Limb Amputation Experience in Individuals with Peripheral Vascular Diseases - Systematic Review Protocol of Qualitative Data Amputation Experience in Individuals with Peripheral Vascular Diseases." CURARE Journal of Nursing, no. 5 (July 5, 2024): 17–26. http://dx.doi.org/10.26650/curare.2024.1445487.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Cookman, Brock, Suhail Allaqaband, and Tonga Nfor. "Non-coronary Interventions: An Introduction to Peripheral Arterial Interventions." Interventional Cardiology Review 11, no. 2 (2016): 128. http://dx.doi.org/10.15420/icr.2016:8:2.

Full text

Abstract:

With an ageing population, the burden of peripheral artery diseases (PADs) is increasing. The treatment of these diseases has largely been performed by interventional radiologists, vascular surgeons and interventional cardiologists. Due to the strong relationship between PAD and overall cardiovascular morbidity and mortality, cardiologists need to play a greater role in the management of PAD. The physician who cares for the patient with peripheral vascular disease should have a broad understanding of atherosclerotic disease involving all vascular beds. Endovascular interventions play a major role in relieving symptoms and reducing morbidity related to PAD, but long-term optimal medical treatment is an essential determinant of prognosis. This paper reviews current endovascular/percutaneous interventions for PAD.

APA, Harvard, Vancouver, ISO, and other styles

40

Jia, Nailong, Long Fan, Chuizhi Wang, Qimao Fu, Yan Chen, Changkun Lin, and Yupeng Zhang. "Subclinical Diabetic Peripheral Vascular Disease and Epidemiology Using Logistic Regression Mathematical Model and Medical Image Registration Algorithm." Journal of Healthcare Engineering 2022 (January 17, 2022): 1–8. http://dx.doi.org/10.1155/2022/2116224.

Full text

Abstract:

The study aims to explore the effect of subclinical diabetic peripheral vascular disease and an epidemiological investigation of colour Doppler ultrasound images based on a logistic regression mathematical model and a medical image registration algorithm. Subclinical diabetes patients were selected as subjects, and after ultrasound colour Doppler ultrasonography of peripheral blood vessels, ultrasound images were taken. The experimental results show that the area under the curve (AUC) predicted by the model was 0.748, the sensitivity was 94.12%, and the specificity was 67.93%. All Δ were smaller than a single pixel. The detection rate of colour Doppler ultrasonography was 82.6%, which was significantly better than that of clinical examination ( P < 0.01 ). The age, course of disease, SBP, low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and triglyceride (TG) of the peripheral vascular disease group were significantly different from those of the no peripheral vascular disease group ( P < 0.05 ). The incidence of peripheral vascular diseases and nonperipheral vascular diseases in male patients was remarkably higher than that in female patients ( P < 0.05 ). Moreover, with the increase of age, the incidence of peripheral vascular disease and nonperipheral vascular disease in diabetic patients showed a trend of gradual increase ( P < 0.05 ). In summary, the mathematical model and registration method have high accuracy for medical image registration of patients with the diabetes epidemic. In addition, the age, course of disease, SBP, LDL-C, TG, and TC of diabetic patients were significantly different from those of normal people, which can provide a reference for the development of later diabetes epidemiology.

APA, Harvard, Vancouver, ISO, and other styles

41

Aithagani, Ramachandraiah, and Nagaraju Gundigari. "TO COMPARE CT PERIPHERAL ANGIOGRAPHY AND NON ENHANCED MAGNETIC RESONANCE PERIPHERAL ANGIOGRAPHY IN EVALUATION OF PERIPHERAL VASCULAR DISEASES." Journal of Evidence Based Medicine and Healthcare 5, no. 46 (November 12, 2018): 3233–38. http://dx.doi.org/10.18410/jebmh/2018/658.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

TSUBOI, Hidetoshi, Haruhiko OKADA, Kazuya NISHIDA, Kazuhiro SUZUKI, Akihiko FURUNAGA, Kimikazu HAMANO, Yoshihiko FUJIMURA, and Kensuke ESATO. "MANAGEMENT OF AORITIC AND PERIPHERAL VASCULAR DISEASES WITH CORONARY ARTERY DISEASE." Journal of the Japanese Practical Surgeon Society 55, no. 9 (1994): 2193–97. http://dx.doi.org/10.3919/ringe1963.55.2193.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Prem Singh, Sanjay Kumar, Koushik Biswas, Abha Jyoti, and Amarendra Tripathi. "Vitamin D status in peripheral vascular diseases: A longitudinal prospective study." Asian Journal of Medical Sciences 13, no. 7 (July 1, 2022): 113–18. http://dx.doi.org/10.3126/ajms.v13i7.43387.

Full text

Abstract:

Background: Peripheral artery disease (PAD) is due to abnormal Narrowing of arteries other than heart and brain (primarily due to atherosclerosis). PAD is the most common form of PVD. Aims and Objectives: In the present study, we analyzed Vitamin D association with peripheral vascular diseases as well as coagulation and inflammation parameters. Materials and Methods: The study was conducted for 100 PAD patients of 18–70 years age and divided in Group I≤20ng/ml and Group II>20ng/ml for serum Vitamin D level. A single, oral, and high- dose Vitamin D3 supplementation 1,20,000IU was given in GroupI. At baseline and at the end of the study after 1 month, Ankle Brachial Index, modified Rankin Scale, Vitamin D, Inflammation and coagulation parameter, HbA1c, etc., were performed in all patients. Evaluation was done using SPSS. The level P<0.05 was considered as the cut off value of significance. Results: The majority of the PAD patients were Vitamin D deficient and have higher HbA1c level with statistically significant (P<0.05) association. This is because low Vitamin D is the risk factor for diabetes in which HbA1c level is higher. Conclusion: Asingle, oral, and high-dose Vitamin D3 supplementation did not alter parameters of inflammation and hemostasis in patients with peripheral arterial disease, adding more data to other studies that did not confirm a causal role of Vitamin D in cardiovascular disease.

APA, Harvard, Vancouver, ISO, and other styles

44

YAMAGUCHI, Hiroshi, Tetsuya OSADA, Takashi SHIMIZU, Shin ISHIMARU, and Kin-ichi FURUKAWA. "Effect of prostanoids on red cell deformability in peripheral vascular diseases." Blood & Vessel 19, no. 1 (1988): 97–99. http://dx.doi.org/10.2491/jjsth1970.19.97.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Korogi, Yukunori, Mutsumasa Takahashi, Masayuki Miyawaki, and Hiromasa Bussaka. "Diagnostic accuracy of intravenous digital subtraction angiography for peripheral vascular diseases." Computerized Radiology 9, no. 6 (November 1985): 341–45. http://dx.doi.org/10.1016/0730-4862(85)90118-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Naaz, Dr Ayesha, and Dr Sapna Salodiya. "Case reports - peripheral vascular diseases presenting with gangrene and homoeopathic medicines." International Journal of Homoeopathic Sciences 4, no. 1 (January 1, 2020): 105–9. http://dx.doi.org/10.33545/26164485.2020.v4.i1b.135.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Heidrich. "Frequency of non-vascular accompanying diseases in patients with peripheral arterial disease." Vasa 33, no. 3 (August 1, 2004): 155–58. http://dx.doi.org/10.1024/0301-1526.33.3.155.

Full text

Abstract:

Background: Since there are so far no relevant figures on the frequency of non-vascular associated diseases in patients with peripheral arterial disease (PAD), an analysis was carried out to determine how frequently co-morbidity is found in such patients. Patients and methods: In the course of a retrospective analysis, 1693 patients (55.4% men, 44.6% women/average 68.6 years) with peripheral arterial diseases (PAD) of Fontaine stage II to IV were examined to find out how often cardiopulmonary, gastrointestinal, haematological, endocrinological, neurological, orthopaedic, urological-nephrological, psychiatric diseases and tumours were seen. Result: Coronary ischaemic heart disease was present in 63.1% of the cases, heart failure existed in 20.7%, hypertension in 57.9%, endocrine and metabolic diseases in 60.4%, gastrointestinal diseases in 14.8%, pulmonary diseases in 14.5%, psychological and behavioural deficiencies in 16.2%, orthopaedic diseases in 21.6%, haematological diseases in 9.0%, urological diseases in 16.9%, chronic renal insufficiency in 7.3% and malignant tumours in 5.8%. Conclusions: The frequency of non-vascular co-morbidity in patients with PAD necessitates systematic interdisciplinary diagnosis prior to any therapy decision to take into account the patient’s associated diseases, life expectancy and current quality of life.

APA, Harvard, Vancouver, ISO, and other styles

48

Phuoc, Dang Ha, Pham Minh Anh, and Vo Tuan Anh. "Early results of endovascular treatment of peripheral artery diseases at Dong Nai General Hospital." Tạp chí Phẫu thuật Tim mạch và Lồng ngực Việt Nam 36 (February 11, 2022): 83–89. http://dx.doi.org/10.47972/vjcts.v36i.742.

Full text

Abstract:

Introduction: Peripheral artery disease is a chronic disease with long-term progression and risk of disability. Treatment includes surgery and endovascular interventions, the latter is becoming more and more developed. This approach has good early and medium-term outcomes Subjects: We report 07 cases of patients diagnosed with peripheral arterial disease who received endovascular intervention at Dong Nai General Hospital. Results: 7 patients with peripheral vascular disease was treated with endovascular approach at Dong Nai General Hospital. Stenosis or chronic occlusion of the superficial femoral artery accounts for 50% of cases, the rest are stenosis of common iliac arteries, external iliac arteries and below-the-knee lesions. The primary intervention results were good, there were no serious complications, the rate of early vascular patency was 100%, the wound healing rate was 100%, there were 3 cases with stenting after balloon angioplasty and 3 cases of minor amputation. No reintervention was needed in these patients. Conclusion: The initial results of endovascular intervention for peripheral vascular disease at Dong Nai General Hospital are encouraging, helping to expand the indications for intervention, including hybrid surgery and creating first steps in multispecialty treatment of cardiovascular disease, a new trend in the future.

APA, Harvard, Vancouver, ISO, and other styles

49

Kalman, Bernadette, Fred D. Lublin, and Hansjuerg Alder. "Impairment of central and peripheral myelin in mitochondrial diseases." Multiple Sclerosis Journal 2, no. 6 (January 1997): 267–78. http://dx.doi.org/10.1177/135245859700200602.

Full text

Abstract:

Clinical or sub-clinical impairment of central and peripheral myelin is of ten part of the overlapping multisystem disorders associated with a variety of mitochondrial (mt)DNA abnormalities. Suboptimal energy metabolism of the oligodendrocytes and Schwann cells carrying mitochondrial defects may cause insufficient production of myelin. Further, edema, vascular and toxic factors may directly damage myelin. The recognition that certain mtDNA point mutations are associated with inflammatory demyelination of the central nervous system suggests that additional mechanisms besides degeneration need to be considered in the development of some forms of myelin damage.

APA, Harvard, Vancouver, ISO, and other styles

50

Yetkin, Ertan, and Selcuk Ozturk. "Dilating Vascular Diseases: Pathophysiology and Clinical Aspects." International Journal of Vascular Medicine 2018 (August 26, 2018): 1–9. http://dx.doi.org/10.1155/2018/9024278.

Full text

Abstract:

Atherosclerotic disease of the vessels is a significant problem affecting mortality and morbidity all over the world. However, dilatation of the vessels either in the arterial system or in the venous territory is another vessel disease. Varicocele, pelvic, and peripheral varicose veins and hemorrhoids are aneurysms of the venous vascular regions and have been defined as dilating venous disease, recently. Coronary artery ectasia, intracranial aneurysm, and abdominal aortic aneurysm are examples of arterial dilating vascular diseases. Mostly, they have been defined as variants of atherosclerosis. Although there are some similarities in terms of pathogenesis, they are distinct from atherosclerotic disease of the vessels. In addition, pathophysiological and histological similarities and clinical coexistence of these diseases have been demonstrated both in the arterial and in the venous system. This situation underlies the thought that dilatation of the vessels in any vascular territory should be considered as a systemic vessel wall disease rather than being a local disease of any vessel. These patients should be evaluated for other dilating vascular diseases in a systematic manner.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!